We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+3.76%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$910M
AUM Growth
-$281M
Cap. Flow
-$283M
Cap. Flow %
-31.16%
Top 10 Hldgs %
40.89%
Holding
141
New
25
Increased
18
Reduced
31
Closed
51

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$27.6M
2
AMZN icon
Amazon
AMZN
+$13.8M
3
FIVN icon
FIVE9
FIVN
+$12.7M
4
SNY icon
Sanofi
SNY
+$11.9M
5
S icon
SentinelOne
S
+$11.7M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$47.9M
2
PFE icon
Pfizer
PFE
+$43.5M
3
ABBV icon
AbbVie
ABBV
+$15.6M
4
AZN icon
AstraZeneca
AZN
+$13.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 68.66%
2 Technology 9.03%
3 Consumer Discretionary 4.71%
4 Communication Services 2.8%
5 Industrials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
26
DELISTED
Merus
MRUS
$10.8M 1.19%
340,951
+31,524
+10% +$891K
RLMD icon
27
Relmada Therapeutics
RLMD
$557M
$10.8M 1.18%
+478,208
New +$10.6M
VRNT
28
DELISTED
Verint Systems
VRNT
$10.5M 1.15%
200,000
+50,000
+33% +$2.4M
S icon
29
SentinelOne
S
$6.53B
$10.1M 1.11%
+199,824
New +$11.7M
ARYD
30
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$9.93M 1.09%
1,000,000
– –
LESL icon
31
Leslie's
LESL
$8.9M
$8.81M 0.97%
18,628
+11,128
+148% +$4.8M
PTGX icon
32
CALL
Protagonist Therapeutics
PTGX
$8.79B
$8.55M 0.94%
250,000
– –
IMTX icon
33
Immatics
IMTX
$1.18B
$8.36M 0.92%
621,925
-178,118
-22% -$2.23M
LENZ
34
LENZ Therapeutics
LENZ
$166M
$8.24M 0.91%
94,742
+18,846
+25% +$1.56M
ISEE
35
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.11M 0.89%
485,001
– –
ABNB icon
36
Airbnb
ABNB
$89.9B
$7.94M 0.87%
+47,689
New +$8.4M
VTGN icon
37
VistaGen Therapeutics
VTGN
$9.89M
$7.85M 0.86%
134,165
+6,667
+5% +$434K
RUN icon
38
CALL
Sunrun
RUN
$2.34B
$7.82M 0.86%
+228,000
New +$10.7M
HOWL icon
39
Werewolf Therapeutics
HOWL
$17.2M
$7.72M 0.85%
648,391
-40,084
-6% -$605K
VINC
40
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$7.34M 0.81%
36,008
+3,279
+10% +$818K
CSTE icon
41
Caesarstone
CSTE
$72.3M
$7.3M 0.8%
644,146
– –
ASAN icon
42
Asana
ASAN
$1.92B
$7.19M 0.79%
+96,500
New +$10.2M
ZLAB icon
43
Zai Lab
ZLAB
$2.06B
$7.02M 0.77%
111,641
-34,341
-24% -$2.91M
KROS icon
44
Keros Therapeutics
KROS
$199M
$7M 0.77%
+119,681
New +$5.97M
TEVA icon
45
Teva Pharmaceuticals
TEVA
$40.8B
$6.67M 0.73%
832,877
-1
-0% -$9
CLDX icon
46
Celldex Therapeutics
CLDX
$2.99B
$6.44M 0.71%
166,766
+36,436
+28% +$1.59M
IMUX icon
47
Immunic
IMUX
$190M
$6.38M 0.7%
66,660
+27,679
+71% +$2.49M
TEAD
48
Teads Holding Co
TEAD
$68.7M
$6.04M 0.66%
431,194
– –
EPIX
49
DELISTED
ESSA Pharma
EPIX
$6M 0.66%
422,461
-46,941
-10% -$523K
KZR
50
DELISTED
Kezar Life Sciences
KZR
$5.64M 0.62%
+33,729
New +$3.81M
1
2
3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sphera Funds Management held 141 positions worth $910M, down 24% from $1.19B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sphera Funds Management withdrew a net $283M in Q4 2021, closing 51 positions and reducing 31 holdings. Its most notable exit was SolarEdge, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Merck worth $26.6M.

  • Sphera Funds Management's largest Q4 2021 buy was Merck: 346,423 shares worth $26.6M.
  • Sphera Funds Management added most to Amazon in Q4 2021, an estimated $13.8M increase.
  • Sphera Funds Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $47.9M.
  • Sphera Funds Management fully exited SolarEdge in Q4 2021, selling an estimated $13.3M.
  • Sphera Funds Management's ten largest holdings make up 41% of its $910M portfolio in Q4 2021.
  • Sphera Funds Management opened 25 new positions and closed 51 in Q4 2021.
  • Sphera Funds Management's portfolio value fell 24% quarter-over-quarter to $910M.

Based on Sphera Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.